Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) is collaborating with Hilleman Laboratories, a Singa...
Alteogen Inc., a South Korea-based biopharmaceutical company specialising in platform technologies, has entered into an ...
Scientists at Northwestern University have found that tissue environments surrounding persistent viral reservoirs share ...
The Ministry of Higher Education, Science & Technology, Republic of Indonesia is partnering with IIT Madras Global R...
MGI Australia, the local Australia and New Zealand (ANZ) team of MGI Tech, has entered a Memorandum of Understanding (Mo...
The collaboration between Monash, Australia’s largest university, leading Japanese information technology company ...
CREATE Medicines, Inc., a US-based clinical-stage biotechnology company pioneering in vivo immune programming, has annou...
J-Pharma has built its pipeline around amino acid transporter (LAT1)-targeted therapies. What was the vision behind this...
Bispecific antibodies have transformed treatment by simultaneously targeting two molecules, delivering significant clini...
For patients living with a rare disorder, receiving an accurate diagnosis can take years. Misdiagnosis often leads to un...
Japan-based Ono Pharmaceutical and US-based Phylo, Inc. have announced a collaboration that brings Biomni Lab, Phylo's a...
Nippon Kayaku and Celltrion Healthcare Japan K.K. have entered into a Memorandum of Understanding (MoU) on Compreh...
Harbour BioMed, a US-based biopharmaceutical company, has entered into a strategic collaboration with China Nationa...
The University of Auckland has established a new Department of Cancer Sciences, bringing together leading researchers, c...
South Korea-based startup Progeneer has signed a non-exclusive licensing agreement worth up to $390 million (approximate...
Australia's Monash University is partnering with key institutions to launch a $2.9 million national project, delivering ...
The National Initiative for RNA Biology and its Applications (NIRBA) has officially opened its new Hub at the National U...
Devonian Health Group has received Health Canada authorisation to initiate a Phase II/III paediatric clinical trial of P...
US-based BostonGene, the developer of the leading AI model for tumour and immune biology, has announced a strategic...
The Ministry of Health and Welfare (MoHW), South Korea, and Novartis have signed a Memorandum of Understanding (MoU) und...
The Chinese University of Hong Kong (CUHK); the People’s Government of Nansha District, Guangzhou; and Guangzhou F...
ING has examined the shifting global pharmaceutical landscape in a podcast discussion focused on China’s biotech b...
Tikva Allocell, a Singapore-based biotechnology startup developing engineered, allogeneic (donor-derived) cell therapies...
Exosomes are rapidly emerging as one of the most promising frontiers in regenerative medicine, offering the therapeutic ...
A “precision guided” CAR T-cell therapy designed at Peter MacCallum Cancer Centre, Australia’s on...
